Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Framarini

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2024
Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centersManuela Robella, Marco Vaira, Luca Ansaloni, et al.
JAMA Surgery|November 27, 2024
Prophylactic Drain Placement and Postoperative Invasive Procedures After Gastrectomy: The Abdominal Drain After Gastrectomy (ADIGE) Randomized Clinical TrialJacopo Weindelmayer, Valentina Mengardo, Filippo Ascari, et al.
Journal of Translational Medicine|April 18, 2025
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trialJenny Bulgarelli, Claudia Piccinini, Emanuela Scarpi, et al.
Annals of Surgical Oncology|November 16, 2021
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Annals of Surgical Oncology|October 13, 2023
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score AnalysisMarco Tonello, Dario Baratti, Paolo Sammartino, et al.
American Journal of Surgery|February 15, 2025
Hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal metastasis - Joint analysis of European GASTRODATA and American national cancer databaseZuzanna Pelc, Katarzyna Sędłak, Yutaka Endo, et al.
Annals of Surgical Oncology|July 27, 2025
Staging Laparoscopy in Gastric Cancer Patients Treated with Curative Intent: A European GASTRODATA Cohort StudyKatarzyna Sędłak, Sebastian Kobiałka, Zuzanna Pelc, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 4, 2016
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015Giovanni De Manzoni, Daniele Marrelli, Gian Luca Baiocchi, et al.
International Journal of Cancer|May 28, 2025
Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysisZuzanna Pelc, Katarzyna Sędłak, Radosław Mlak, et al.
Cancers|October 2, 2020
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II TrialManlio Monti, Paolo Morgagni, Oriana Nanni, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2024
Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centersManuela Robella, Marco Vaira, Luca Ansaloni, et al.
JAMA Surgery|November 27, 2024
Prophylactic Drain Placement and Postoperative Invasive Procedures After Gastrectomy: The Abdominal Drain After Gastrectomy (ADIGE) Randomized Clinical TrialJacopo Weindelmayer, Valentina Mengardo, Filippo Ascari, et al.
Journal of Translational Medicine|April 18, 2025
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trialJenny Bulgarelli, Claudia Piccinini, Emanuela Scarpi, et al.
Annals of Surgical Oncology|November 16, 2021
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Annals of Surgical Oncology|October 13, 2023
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score AnalysisMarco Tonello, Dario Baratti, Paolo Sammartino, et al.
American Journal of Surgery|February 15, 2025
Hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal metastasis - Joint analysis of European GASTRODATA and American national cancer databaseZuzanna Pelc, Katarzyna Sędłak, Yutaka Endo, et al.
Annals of Surgical Oncology|July 27, 2025
Staging Laparoscopy in Gastric Cancer Patients Treated with Curative Intent: A European GASTRODATA Cohort StudyKatarzyna Sędłak, Sebastian Kobiałka, Zuzanna Pelc, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 4, 2016
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015Giovanni De Manzoni, Daniele Marrelli, Gian Luca Baiocchi, et al.
International Journal of Cancer|May 28, 2025
Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysisZuzanna Pelc, Katarzyna Sędłak, Radosław Mlak, et al.
Cancers|October 2, 2020
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II TrialManlio Monti, Paolo Morgagni, Oriana Nanni, et al.
Pageof 6